NCT04584801 (SLPCOPD) is a clinical trial of Structured Light Plethysmography in COPD, sponsored by Pneumacare Ltd.

Who is sponsoring NCT04584801?

NCT04584801 is sponsored by Pneumacare Ltd.

What drugs are being tested in NCT04584801?

Interventions in NCT04584801: Structured Light Plethysmography.

What condition does NCT04584801 study?

NCT04584801 studies COPD, Healthy Smoker.

Is NCT04584801 still recruiting?

NCT04584801 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT04584801: SLPCOPD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SLP Model Development in the Diagnosis of COPD Patients

Completed Last updated 19 September 2024

What this trial tests

trial testing Structured Light Plethysmography in COPD in 201 participants. Completed in 15 June 2023.

Timeline

5 May 2021

Primary endpoint
15 June 2023

15 June 2023

Quick facts

Lead sponsor	Pneumacare Ltd
Status	Completed
Study type	OBSERVATIONAL
Enrollment	201
Start date	5 May 2021
Primary completion	15 June 2023
Estimated completion	15 June 2023
Sites	7 locations across United Kingdom

Drugs / interventions tested

Structured Light Plethysmography

Conditions studied

COPD — all drugs for COPD →
Healthy Smoker — all drugs for Healthy Smoker →

Sponsor

Pneumacare Ltd

Who can join

18 and older, any sex, with COPD or Healthy Smoker. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, comparative, multicentre study to develop a model for the Thora3Di™ against standard practice in patients who are undergoing investigation for COPD. The core methodology involves capturing of data during a short period of measurement of breathing using SLP against spirometric outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Structured Light Plethysmography

Trials testing the same drug.

NCT03499938 — Structured Light Plethysmography in Obstructive Airways Disease · completed

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04584801 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pneumacare Ltd
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04584801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing